10-Q Filing

REGENXBIO INC. CIK: 1590877 Q2 2023

Filing Information

Form Type	10-Q
Accession Number	`0000950170-23-037178`
Period End Date	20230630
Filing Date	20230802
Fiscal Year	2023
Fiscal Period	Q2
XBRL Instance	rgnx-20230630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 82 Income Statement 81 Cash Flow Statement 65 Stockholders Equity 32

Balance Sheet 82 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$68.60M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$121.37M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$96.95M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$267.69M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$251.48M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$21.38M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$28.08M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$15.11M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$13.90M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	43.30M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	43.62M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$22.23M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$9.35M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$378.81M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	43.30M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$415.98M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	43.62M	shares	Point-in-time
Marketable securities	`MarketableSecuritiesNoncurrent`	$95.30M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesNoncurrent`	$200.56M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetNoncurrent`	$1.50M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetNoncurrent`	$1.14M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$138.68M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$141.69M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$62.44M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$65.12M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$2.25M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$2.03M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsNoncurrent`	$2.03M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$3.83M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$6.40M	USD	Point-in-time
Total assets	`Assets`	$833.27M	USD	Point-in-time
Total assets	`Assets`	$682.46M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$11.64M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$27.21M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedExpensesAndOtherCurrentLiabilities`	$46.79M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedExpensesAndOtherCurrentLiabilities`	$50.52M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$1.83M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$448.00K	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$6.33M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$6.00M	USD	Point-in-time
Liability related to sale of future royalties	`LiabilityRelatedToSaleOfFutureRoyaltiesCurrent`	$48.96M	USD	Point-in-time
Liability related to sale of future royalties	`LiabilityRelatedToSaleOfFutureRoyaltiesCurrent`	$48.60M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$117.89M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$130.43M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$85.25M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$88.80M	USD	Point-in-time
Liability related to sale of future royalties	`LiabilityRelatedToSaleOfFutureRoyaltiesNonCurrent`	$89.00M	USD	Point-in-time
Liability related to sale of future royalties	`LiabilityRelatedToSaleOfFutureRoyaltiesNonCurrent`	$67.38M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$6.08M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$8.83M	USD	Point-in-time
Total liabilities	`Liabilities`	$317.07M	USD	Point-in-time
Total liabilities	`Liabilities`	$276.60M	USD	Point-in-time
Preferred stock; $0.0001 par value; 10,000 shares authorized, no shares issued and outstanding at June 30, 2023 and December 31, 2022	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock; $0.0001 par value; 10,000 shares authorized, no shares issued and outstanding at June 30, 2023 and December 31, 2022	`PreferredStockValue`	-	USD	Point-in-time
Common stock; $0.0001 par value; 100,000 shares authorized at June 30, 2023 and December 31, 2022; 43,621 and 43,299 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively	`CommonStockValue`	$4.00K	USD	Point-in-time
Common stock; $0.0001 par value; 100,000 shares authorized at June 30, 2023 and December 31, 2022; 43,621 and 43,299 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively	`CommonStockValue`	$4.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$973.14M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$996.24M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-15.40M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-10.10M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-580.29M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-441.55M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$764.30M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$465.14M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$689.67M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$405.86M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$630.52M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$516.20M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$833.27M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$682.46M	USD	Point-in-time

Income Statement 81 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$32.65M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$19.98M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$39.12M	USD	2 Qtrs
Revenues	`RevenueFromContractWithCustomerExcludingAssessedTax`	$54.87M	USD	2 Qtrs
Cost of revenues	`CostOfGoodsAndServicesSold`	$13.59M	USD	2 Qtrs
Cost of revenues	`CostOfGoodsAndServicesSold`	$28.67M	USD	2 Qtrs
Cost of revenues	`CostOfGoodsAndServicesSold`	$9.47M	USD	1 Quarter
Cost of revenues	`CostOfGoodsAndServicesSold`	$12.95M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$116.64M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$61.01M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$118.40M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$59.89M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$20.83M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$43.15M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$46.33M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$23.70M	USD	1 Quarter
Other operating expenses	`OtherOperatingExpenses`	$26.00K	USD	1 Quarter
Other operating expenses	`OtherOperatingExpenses`	$474.00K	USD	2 Qtrs
Other operating expenses	`OtherOperatingExpenses`	$391.00K	USD	1 Quarter
Other operating expenses	`OtherOperatingExpenses`	$59.00K	USD	2 Qtrs
Total operating expenses	`CostsAndExpenses`	$178.38M	USD	2 Qtrs
Total operating expenses	`CostsAndExpenses`	$95.18M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$188.93M	USD	2 Qtrs
Total operating expenses	`CostsAndExpenses`	$93.08M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-73.11M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-62.53M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-134.06M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-139.26M	USD	2 Qtrs
Interest income from licensing	`InterestIncomeFromLicencing`	$153.00K	USD	1 Quarter
Interest income from licensing	`InterestIncomeFromLicencing`	$40.00K	USD	1 Quarter
Interest income from licensing	`InterestIncomeFromLicencing`	$110.00K	USD	2 Qtrs
Interest income from licensing	`InterestIncomeFromLicencing`	$247.00K	USD	2 Qtrs
Investment income	`InvestmentIncomeNet`	$2.13M	USD	1 Quarter
Investment income	`InvestmentIncomeNet`	$4.29M	USD	2 Qtrs
Investment income	`InvestmentIncomeNet`	$1.06M	USD	1 Quarter
Investment income	`InvestmentIncomeNet`	$1.86M	USD	2 Qtrs
Interest expense	`InterestExpense`	$1.12M	USD	1 Quarter
Interest expense	`InterestExpense`	$6.86M	USD	1 Quarter
Interest expense	`InterestExpense`	$12.99M	USD	2 Qtrs
Interest expense	`InterestExpense`	$3.88M	USD	2 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$1.05M	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$-10.88M	USD	2 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$-5.65M	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$528.00K	USD	2 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-138.74M	USD	2 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-144.94M	USD	2 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-68.18M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-72.06M	USD	1 Quarter
Income Tax Benefit	`IncomeTaxExpenseBenefit`	$-41.00K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-138.74M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-144.90M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-68.18M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-72.06M	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-12.19M	USD	2 Qtrs
Unrealized gain (loss) on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$1.52M	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$5.30M	USD	2 Qtrs
Unrealized gain (loss) on available-for-sale securities, net	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-2.81M	USD	1 Quarter
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$1.52M	USD	1 Quarter
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-2.81M	USD	1 Quarter
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-12.19M	USD	2 Qtrs
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$5.30M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-157.10M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-70.99M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-133.43M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-70.54M	USD	1 Quarter
Net loss per share, basic	`EarningsPerShareBasic`	$-3.19	USD	2 Qtrs
Net loss per share, basic	`EarningsPerShareBasic`	$-3.37	USD	2 Qtrs
Net loss per share, basic	`EarningsPerShareBasic`	$-1.58	USD	1 Quarter
Net loss per share, basic	`EarningsPerShareBasic`	$-1.66	USD	1 Quarter
Net loss per share, diluted	`EarningsPerShareDiluted`	$-3.19	USD	2 Qtrs
Net loss per share, diluted	`EarningsPerShareDiluted`	$-1.58	USD	1 Quarter
Net loss per share, diluted	`EarningsPerShareDiluted`	$-1.66	USD	1 Quarter
Net loss per share, diluted	`EarningsPerShareDiluted`	$-3.37	USD	2 Qtrs
Weighted-average common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	43,491.00	shares	2 Qtrs
Weighted-average common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	43,531.00	shares	1 Quarter
Weighted-average common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	43,028.00	shares	2 Qtrs
Weighted-average common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	43,111.00	shares	1 Quarter
Weighted-average common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	43,111.00	shares	1 Quarter
Weighted-average common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	43,531.00	shares	1 Quarter
Weighted-average common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	43,491.00	shares	2 Qtrs
Weighted-average common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	43,028.00	shares	2 Qtrs

Cash Flow Statement 65 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-138.74M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-144.90M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$21.14M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$21.71M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$5.23M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$8.61M	USD	2 Qtrs
Net amortization of premiums on marketable debt securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-1.06M	USD	2 Qtrs
Net amortization of premiums on marketable debt securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-2.68M	USD	2 Qtrs
Net loss on investments	`GainLossOnInvestments`	$-72.00K	USD	2 Qtrs
Imputed interest income from licensing	`ImputedInterestIncomeFromLicensing`	$247.00K	USD	2 Qtrs
Imputed interest income from licensing	`ImputedInterestIncomeFromLicensing`	$110.00K	USD	2 Qtrs
Non-cash interest expense	`NonCashInterestExpense`	$-1.24M	USD	2 Qtrs
Non-cash interest expense	`NonCashInterestExpense`	$874.00K	USD	2 Qtrs
Other non-cash adjustments	`OtherNoncashIncomeExpense`	$-308.00K	USD	2 Qtrs
Other non-cash adjustments	`OtherNoncashIncomeExpense`	$55.00K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$5.03M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-7.11M	USD	2 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$1.21M	USD	2 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-2.51M	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$12.85M	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-1.44M	USD	2 Qtrs
Operating lease right-of-use assets	`IncreaseDecreaseInOperatingLeaseRightOfUseAssets`	$-2.02M	USD	2 Qtrs
Operating lease right-of-use assets	`IncreaseDecreaseInOperatingLeaseRightOfUseAssets`	$-2.81M	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$-2.56M	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$-523.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$9.53M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayableTrade`	$-14.11M	USD	2 Qtrs
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-25.59M	USD	2 Qtrs
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$3.50M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$3.47M	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-1.21M	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$547.00K	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-3.35M	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$7.78M	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-2.74M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-128.24M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-117.66M	USD	2 Qtrs
Purchases of marketable debt securities	`PaymentsToAcquireMarketableSecurities`	$158.36M	USD	2 Qtrs
Purchases of marketable debt securities	`PaymentsToAcquireMarketableSecurities`	$49.80M	USD	2 Qtrs
Maturities of marketable debt securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$175.50M	USD	2 Qtrs
Maturities of marketable debt securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$86.89M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$7.39M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$20.20M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-91.67M	USD	2 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$118.31M	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$1.84M	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$1.22M	USD	2 Qtrs
Taxes paid related to net settlement of stock-based awards	`TaxesPaidRelatedToNetSettlementOfStockBasedAwards`	$419.00K	USD	2 Qtrs
Taxes paid related to net settlement of stock-based awards	`TaxesPaidRelatedToNetSettlementOfStockBasedAwards`	$284.00K	USD	2 Qtrs
Proceeds from issuance of common stock under employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans`	$622.00K	USD	2 Qtrs
Proceeds from issuance of common stock under employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans`	$583.00K	USD	2 Qtrs
Repayments under liability related to sale of future royalties, net of imputed interest	`RepaymentsUnderLiabilityRelatedToSaleOfFutureRoyalties`	$19.58M	USD	2 Qtrs
Repayments under liability related to sale of future royalties, net of imputed interest	`RepaymentsUnderLiabilityRelatedToSaleOfFutureRoyalties`	$16.68M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-14.50M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-18.20M	USD	2 Qtrs
Net decrease in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-28.13M	USD	2 Qtrs
Net decrease in cash and cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-223.84M	USD	2 Qtrs
Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$98.98M	USD	Point-in-time
Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$347.24M	USD	Point-in-time
Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$123.40M	USD	Point-in-time
Beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$70.86M	USD	Point-in-time
End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$98.98M	USD	Point-in-time
End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$347.24M	USD	Point-in-time
End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$123.40M	USD	Point-in-time
End of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$70.86M	USD	Point-in-time

Stockholders Equity 32 line items

Line Item	Tag	Value	Unit	Period
Balances	`StockholdersEquity`	$764.30M	USD	Point-in-time
Balances	`StockholdersEquity`	$465.14M	USD	Point-in-time
Balances	`StockholdersEquity`	$689.67M	USD	Point-in-time
Balances	`StockholdersEquity`	$405.86M	USD	Point-in-time
Balances	`StockholdersEquity`	$630.52M	USD	Point-in-time
Balances	`StockholdersEquity`	$516.20M	USD	Point-in-time
Vesting of restricted stock units, net of tax	`VestingOfRestrictedStockUnits`	$-284.00K	USD	2 Qtrs
Vesting of restricted stock units, net of tax	`VestingOfRestrictedStockUnits`	$-419.00K	USD	2 Qtrs
Exercise of stock options, net of tax	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.22M	USD	2 Qtrs
Exercise of stock options, net of tax	`StockIssuedDuringPeriodValueStockOptionsExercised`	$749.00K	USD	1 Quarter
Exercise of stock options, net of tax	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.84M	USD	2 Qtrs
Exercise of stock options, net of tax	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.51M	USD	1 Quarter
Issuance of common stock under employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$622.00K	USD	2 Qtrs
Issuance of common stock under employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$583.00K	USD	2 Qtrs
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$21.14M	USD	2 Qtrs
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$10.34M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$10.50M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$21.71M	USD	2 Qtrs
Unrealized gain (loss) on available-for-sale securities, net	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-12.19M	USD	2 Qtrs
Unrealized gain (loss) on available-for-sale securities, net	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-2.81M	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities, net	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$1.52M	USD	1 Quarter
Unrealized gain (loss) on available-for-sale securities, net	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$5.30M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-138.74M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-144.90M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-68.18M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-72.06M	USD	1 Quarter
Balances	`StockholdersEquity`	$764.30M	USD	Point-in-time
Balances	`StockholdersEquity`	$465.14M	USD	Point-in-time
Balances	`StockholdersEquity`	$689.67M	USD	Point-in-time
Balances	`StockholdersEquity`	$405.86M	USD	Point-in-time
Balances	`StockholdersEquity`	$630.52M	USD	Point-in-time
Balances	`StockholdersEquity`	$516.20M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.